Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study
- Conditions
- End-Stage Renal Disease
- Interventions
- Device: urgent-start peritoneal dialysis catheterDevice: central venous catheter
- Registration Number
- NCT02946528
- Lead Sponsor
- RenJi Hospital
- Brief Summary
Within the last decade, urgent-start peritoneal dialysis(PD) has gained considerable interest amongst nephrologists. Several publications have provided assurances that urgent-start PD is indeed feasible and can serve patients well; however, most of the studies have small sample sizes, retrospective design, and the impact of the urgent-start dialysis modality on outcome, especially on short-term complications, has not been directly evaluated. Therefore, we started this multi-centered, prospective, interventional study compared the dialysis-related complications and survival rate directly between urgent-start PD and HD groups with a large sample to determine the feasibility and safety of urgent-start PD as an alternate initial modality of dialysis for patients who require urgent initiation of dialysis therapy.
- Detailed Description
The prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is on the rise worldwide. Moreover, many patients who progress to ESRD, even with regular nephrology follow-up, do not have a distinct plan at the time of initiating dialysis therapy, resulting in an urgent need for dialysis. Urgent-start dialysis refers to urgent initiation of dialysis for ESRD patients with no pre-established functional vascular access or peritoneal dialysis (PD) catheter. Hemodialysis (HD) is preferred in most centers with a high rate of central venous catheter (CVC) use at the time of initiating dialysis among HD patients. There is a significantly increased risk of infectious complications, thrombosis, and other complications associated with CVC use which negatively affects patient prognosis. Within the last decade, urgent-start PD has gained considerable interest amongst nephrologists. Several publications have provided assurances that urgent-start PD is indeed feasible and can serve patients well; however, most of the studies have small sample sizes, and the impact of the urgent-start dialysis modality on outcome, especially on short-term complications, has not been directly evaluated. Therefore, we conducted this multicenter, prospective, randomized clinical trial to compare the dialysis-related complications and survival rate directly between urgent-start PD and HD groups with a large sample to determine the feasibility and safety of urgent-start PD as an alternate initial modality of dialysis for patients who require urgent initiation of dialysis therapy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 116
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description urgent-start peritoneal dialysis urgent-start peritoneal dialysis catheter All patients in urgent-start peritoneal dialysis arm initiate peritoneal dialysis as urgent-start dialysis modality. urgent-start hemodialysis central venous catheter All patients in urgent-start hemodialysis arm initiate hemodialysis as urgent-start dialysis modality.
- Primary Outcome Measures
Name Time Method the incidence of dialysis-related complications 12 months the incidence of dialysis-related complications.Dialysis-related complications were defined as a composite of non-infectious complications (malposition, obstruction, leakage, hernia, bleeding, or thrombosis) and infectious complications (catheterrelated infection, exit-site infection, or peritonitis)
- Secondary Outcome Measures
Name Time Method peritonitis-free survival rates 12 months peritonitis-free survival rates
PD catheter technical survival rate 12 months PD catheter technical survival rate
total medical cost of initial hospitalization 6 weeks total medical cost of initial hospitalization
patient survival rate 12 months patient survival rate
duration of initial hospitalization 6 weeks duration of initial hospitalization
Trial Locations
- Locations (1)
RenJi Hospital
🇨🇳Shanghai, China